At Gillies McIndoe Research Institute we work closely with clinicians and patients to develop new treatments for cancer, vascular anomalies and fibrotic conditions. Using patient-derived 3D culture models to assess repurposed and novel drugs using histology, protein, RNA and cell culture assays.